Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
clindamycin phosphate and tretinoin
Overview
What is VELTIN?
VELTIN (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025%, is
a fixed combination of 2 solubilized active ingredients in an
aqueous-based gel. Clindamycin phosphate is a water soluble ester of the
semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the
7(R)-hydroxyl group of the parent antibiotic lincomycin.
The chemical name for clindamycin phosphate is methyl
7-chloro-6,7,8-trideoxy-6-(1-methyl--4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L--α-D--octopyranoside 2-(dihydrogen phosphate). The
structural formula for clindamycin phosphate is represented below:
Molecular Formula:
CHClNOPS
Molecular Weight: 504.97
The chemical name for tretinoin is all-
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic
acid. It is a member of the retinoid family of compounds.
The structural formula for tretinoin is represented below:
Molecular Formula: CHO
Molecular Weight: 300.44
VELTIN Gel contains the following inactive ingredients: anhydrous
citric acid, butylated hydroxytoluene, carbomer homopolymer (type C),
edetate disodium, laureth 4, methylparaben, propylene glycol, purified
water, and tromethamine.
What does VELTIN look like?






What are the available doses of VELTIN?
VELTIN Gel, containing clindamycin phosphate 1.2% and tretinoin
0.025%, is a yellow, opaque topical gel. Each gram of VELTIN Gel
contains, as dispensed, 10 mg (1%) clindamycin as clindamycin phosphate,
and 0.25 mg (0.025%) tretinoin solubilized in an aqueous-based
gel.
What should I talk to my health care provider before I take VELTIN?
How should I use VELTIN?
VELTIN (clindamycin phosphate and tretinoin) Gel,
1.2%/0.025% is indicated for the topical treatment of acne vulgaris in
patients 12 years and older.
VELTIN Gel should be applied once daily in the evening, gently
rubbing the medication to lightly cover the entire affected area.
Approximately a pea-sized amount will be needed for each application.
Avoid the eyes, lips, and mucous membranes.
VELTIN Gel is not for oral, ophthalmic, or intravaginal
use.
What interacts with VELTIN?
Sorry No Records found
What are the warnings of VELTIN?
Sorry No Records found
What are the precautions of VELTIN?
Sorry No Records found
What are the side effects of VELTIN?
Sorry No records found
What should I look out for while using VELTIN?
VELTIN Gel is contraindicated in patients with regional
enteritis, ulcerative colitis, or history of antibiotic-associated
colitis.
What might happen if I take too much VELTIN?
Sorry No Records found
How should I store and handle VELTIN?
How SuppliedVELTIN Gel is supplied as follows:Storage and HandlingHow SuppliedVELTIN Gel is supplied as follows:Storage and HandlingHow SuppliedVELTIN Gel is supplied as follows:Storage and Handling
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Non-Clinical Toxicology
VELTIN Gel is contraindicated in patients with regional enteritis, ulcerative colitis, or history of antibiotic-associated colitis.The vasodilating effects of isosorbide mononitrate may be additive with those of other vasodilators. Alcohol, in particular, has been found to exhibit additive effects of this variety.
Marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination. Dose adjustments of either class of agents may be necessary.
Systemic absorption of clindamycin has been demonstrated following topical use. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical clindamycin. If significant diarrhea occurs, VELTIN Gel should be discontinued.
Severe colitis has occurred following oral or parenteral administration of clindamycin with an onset of up to several weeks following cessation of therapy. Antiperistaltic agents such as opiates and diphenoxylate with atropine may prolong and/or worsen severe colitis. Severe colitis may result in death.
Studies indicate a toxin(s) produced by clostridia is one primary cause of antibiotic-associated colitis. The colitis is usually characterized by severe persistent diarrhea and severe abdominal cramps and may be associated with the passage of blood and mucus. Stool cultures for and stool assay for toxin may be helpful diagnostically.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).